Your browser doesn't support javascript.
Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations.
Palazzuoli, Alberto; Tecson, Kristen M; McCullough, Peter A.
  • Palazzuoli A; Cardiovascular Diseases Unit, Department of Internal Medicine, Le Scotte Hospital, University of Siena, Siena, Italy.
  • Tecson KM; Baylor University Medical Center, Baylor Heart and Vascular Institute, Texas A&M College of Medicine Health Science Center, Dallas, Texas, USA.
  • McCullough PA; Baylor University Medical Center, Baylor Heart and Vascular Institute, Texas A&M College of Medicine Health Science Center, Dallas, Texas, USA.
J Hypertens ; 39(8): 1725-1726, 2021 08 01.
Article in English | MEDLINE | ID: covidwho-1288138

Full text: Available Collection: International databases Database: MEDLINE Main subject: Renin-Angiotensin System / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: J Hypertens Year: 2021 Document Type: Article Affiliation country: HJH.0000000000002876

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Renin-Angiotensin System / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: J Hypertens Year: 2021 Document Type: Article Affiliation country: HJH.0000000000002876